Global Biopharmaceuticals Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 08-Oct-2021
No. of pages: 110

The Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biopharmaceuticals size is estimated to be USD 41330 million in 2026 from USD 30770 million in 2020, with a change XX% between 2020 and 2021. The global Biopharmaceuticals market size is expected to grow at a CAGR of 7.7% for the next five years.

Market segmentation

Biopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Monoclonal Antibodies

- Interferon

- Colony-Stimulating Factor

- Erythropoietin

- Insulin

- Vaccines

- Growth Hormones

- Others

Market segment by Application, can be divided into

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Others

Market segment by players, this report covers

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

- Sun

- 3sbio

- Changchun High Tech

- CP Guojian

- Biotech

- Gelgen

- Innovent

- Dong Bao

- Ganlee

- United Laboratories

- SANDOZ (NOVARTIS)

- Teva Pharmaceutical

- Hospira ?Pfizer?

- MYLAN

- Sun pharma

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Biopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biopharmaceuticals, with revenue, gross margin and global market share of Biopharmaceuticals from 2019 to 2021.

Chapter 3, the Biopharmaceuticals competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Biopharmaceuticals market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Biopharmaceuticals research findings and conclusion, appendix and data source.

Global Biopharmaceuticals Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Biopharmaceuticals
1.2 Classification of Biopharmaceuticals by Type
1.2.1 Overview: Global Biopharmaceuticals Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biopharmaceuticals Revenue Market Share by Type in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Interferon
1.2.5 Colony-Stimulating Factor
1.2.6 Erythropoietin
1.2.7 Insulin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Others
1.3 Global Biopharmaceuticals Market by Application
1.3.1 Overview: Global Biopharmaceuticals Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Global Biopharmaceuticals Market Size & Forecast
1.5 Global Biopharmaceuticals Market Size and Forecast by Region
1.5.1 Global Biopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biopharmaceuticals Market Size by Region, (2016-2021)
1.5.3 North America Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.4 Europe Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.6 South America Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biopharmaceuticals Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceuticals Market Drivers
1.6.2 Biopharmaceuticals Market Restraints
1.6.3 Biopharmaceuticals Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biopharmaceuticals Product and Solutions
2.1.4 Roche Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biopharmaceuticals Product and Solutions
2.2.4 Amgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biopharmaceuticals Product and Solutions
2.3.4 AbbVie Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 Sanofi-Aventis
2.4.1 Sanofi-Aventis Details
2.4.2 Sanofi-Aventis Major Business
2.4.3 Sanofi-Aventis Biopharmaceuticals Product and Solutions
2.4.4 Sanofi-Aventis Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi-Aventis Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biopharmaceuticals Product and Solutions
2.5.4 Johnson & Johnson Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biopharmaceuticals Product and Solutions
2.6.4 Pfizer Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Biopharmaceuticals Product and Solutions
2.7.4 Novo Nordisk Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novo Nordisk Recent Developments and Future Plans
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Biopharmaceuticals Product and Solutions
2.8.4 Eli Lilly Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eli Lilly Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biopharmaceuticals Product and Solutions
2.9.4 Novartis Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Biopharmaceuticals Product and Solutions
2.10.4 Merck Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Merck Recent Developments and Future Plans
2.11 Sun
2.11.1 Sun Details
2.11.2 Sun Major Business
2.11.3 Sun Biopharmaceuticals Product and Solutions
2.11.4 Sun Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sun Recent Developments and Future Plans
2.12 3sbio
2.12.1 3sbio Details
2.12.2 3sbio Major Business
2.12.3 3sbio Biopharmaceuticals Product and Solutions
2.12.4 3sbio Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 3sbio Recent Developments and Future Plans
2.13 Changchun High Tech
2.13.1 Changchun High Tech Details
2.13.2 Changchun High Tech Major Business
2.13.3 Changchun High Tech Biopharmaceuticals Product and Solutions
2.13.4 Changchun High Tech Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Changchun High Tech Recent Developments and Future Plans
2.14 CP Guojian
2.14.1 CP Guojian Details
2.14.2 CP Guojian Major Business
2.14.3 CP Guojian Biopharmaceuticals Product and Solutions
2.14.4 CP Guojian Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 CP Guojian Recent Developments and Future Plans
2.15 Biotech
2.15.1 Biotech Details
2.15.2 Biotech Major Business
2.15.3 Biotech Biopharmaceuticals Product and Solutions
2.15.4 Biotech Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Biotech Recent Developments and Future Plans
2.16 Gelgen
2.16.1 Gelgen Details
2.16.2 Gelgen Major Business
2.16.3 Gelgen Biopharmaceuticals Product and Solutions
2.16.4 Gelgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Gelgen Recent Developments and Future Plans
2.17 Innovent
2.17.1 Innovent Details
2.17.2 Innovent Major Business
2.17.3 Innovent Biopharmaceuticals Product and Solutions
2.17.4 Innovent Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Innovent Recent Developments and Future Plans
2.18 Dong Bao
2.18.1 Dong Bao Details
2.18.2 Dong Bao Major Business
2.18.3 Dong Bao Biopharmaceuticals Product and Solutions
2.18.4 Dong Bao Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Dong Bao Recent Developments and Future Plans
2.19 Ganlee
2.19.1 Ganlee Details
2.19.2 Ganlee Major Business
2.19.3 Ganlee Biopharmaceuticals Product and Solutions
2.19.4 Ganlee Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Ganlee Recent Developments and Future Plans
2.20 United Laboratories
2.20.1 United Laboratories Details
2.20.2 United Laboratories Major Business
2.20.3 United Laboratories Biopharmaceuticals Product and Solutions
2.20.4 United Laboratories Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 United Laboratories Recent Developments and Future Plans
2.21 SANDOZ (NOVARTIS)
2.21.1 SANDOZ (NOVARTIS) Details
2.21.2 SANDOZ (NOVARTIS) Major Business
2.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Product and Solutions
2.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 SANDOZ (NOVARTIS) Recent Developments and Future Plans
2.22 Teva Pharmaceutical
2.22.1 Teva Pharmaceutical Details
2.22.2 Teva Pharmaceutical Major Business
2.22.3 Teva Pharmaceutical Biopharmaceuticals Product and Solutions
2.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Teva Pharmaceutical Recent Developments and Future Plans
2.23 Hospira ?Pfizer?
2.23.1 Hospira ?Pfizer? Details
2.23.2 Hospira ?Pfizer? Major Business
2.23.3 Hospira ?Pfizer? Biopharmaceuticals Product and Solutions
2.23.4 Hospira ?Pfizer? Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 Hospira ?Pfizer? Recent Developments and Future Plans
2.24 MYLAN
2.24.1 MYLAN Details
2.24.2 MYLAN Major Business
2.24.3 MYLAN Biopharmaceuticals Product and Solutions
2.24.4 MYLAN Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.24.5 MYLAN Recent Developments and Future Plans
2.25 Sun pharma
2.25.1 Sun pharma Details
2.25.2 Sun pharma Major Business
2.25.3 Sun pharma Biopharmaceuticals Product and Solutions
2.25.4 Sun pharma Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.25.5 Sun pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biopharmaceuticals Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceuticals Players Market Share
3.2.2 Top 10 Biopharmaceuticals Players Market Share
3.2.3 Market Competition Trend
3.3 Biopharmaceuticals Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biopharmaceuticals Revenue and Market Share by Type (2016-2021)
4.2 Global Biopharmaceuticals Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)
5.2 Biopharmaceuticals Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceuticals Revenue by Type (2016-2026)
6.2 North America Biopharmaceuticals Revenue by Application (2016-2026)
6.3 North America Biopharmaceuticals Market Size by Country
6.3.1 North America Biopharmaceuticals Revenue by Country (2016-2026)
6.3.2 United States Biopharmaceuticals Market Size and Forecast (2016-2026)
6.3.3 Canada Biopharmaceuticals Market Size and Forecast (2016-2026)
6.3.4 Mexico Biopharmaceuticals Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceuticals Revenue by Type (2016-2026)
7.2 Europe Biopharmaceuticals Revenue by Application (2016-2026)
7.3 Europe Biopharmaceuticals Market Size by Country
7.3.1 Europe Biopharmaceuticals Revenue by Country (2016-2026)
7.3.2 Germany Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.3 France Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.5 Russia Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.6 Italy Biopharmaceuticals Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceuticals Revenue by Type (2016-2026)
8.2 Asia-Pacific Biopharmaceuticals Revenue by Application (2016-2026)
8.3 Asia-Pacific Biopharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Biopharmaceuticals Revenue by Region (2016-2026)
8.3.2 China Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.3 Japan Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.4 South Korea Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.5 India Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.7 Australia Biopharmaceuticals Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceuticals Revenue by Type (2016-2026)
9.2 South America Biopharmaceuticals Revenue by Application (2016-2026)
9.3 South America Biopharmaceuticals Market Size by Country
9.3.1 South America Biopharmaceuticals Revenue by Country (2016-2026)
9.3.2 Brazil Biopharmaceuticals Market Size and Forecast (2016-2026)
9.3.3 Argentina Biopharmaceuticals Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceuticals Revenue by Type (2016-2026)
10.2 Middle East & Africa Biopharmaceuticals Revenue by Application (2016-2026)
10.3 Middle East & Africa Biopharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Biopharmaceuticals Revenue by Country (2016-2026)
10.3.2 Turkey Biopharmaceuticals Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biopharmaceuticals Market Size and Forecast (2016-2026)
10.3.4 UAE Biopharmaceuticals Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Biopharmaceuticals Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biopharmaceuticals Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biopharmaceuticals Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biopharmaceuticals Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biopharmaceuticals Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Biopharmaceuticals Product and Solutions
Table 9. Roche Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Biopharmaceuticals Product and Solutions
Table 13. Amgen Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. AbbVie Corporate Information, Head Office, and Major Competitors
Table 15. AbbVie Major Business
Table 16. AbbVie Biopharmaceuticals Product and Solutions
Table 17. AbbVie Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi-Aventis Major Business
Table 20. Sanofi-Aventis Biopharmaceuticals Product and Solutions
Table 21. Sanofi-Aventis Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Biopharmaceuticals Product and Solutions
Table 25. Johnson & Johnson Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Biopharmaceuticals Product and Solutions
Table 29. Pfizer Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 31. Novo Nordisk Major Business
Table 32. Novo Nordisk Biopharmaceuticals Product and Solutions
Table 33. Novo Nordisk Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 35. Eli Lilly Major Business
Table 36. Eli Lilly Biopharmaceuticals Product and Solutions
Table 37. Eli Lilly Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novartis Corporate Information, Head Office, and Major Competitors
Table 39. Novartis Major Business
Table 40. Novartis Biopharmaceuticals Product and Solutions
Table 41. Novartis Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Merck Corporate Information, Head Office, and Major Competitors
Table 43. Merck Major Business
Table 44. Merck Biopharmaceuticals Product and Solutions
Table 45. Merck Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sun Corporate Information, Head Office, and Major Competitors
Table 47. Sun Major Business
Table 48. Sun Biopharmaceuticals Product and Solutions
Table 49. Sun Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. 3sbio Corporate Information, Head Office, and Major Competitors
Table 51. 3sbio Major Business
Table 52. 3sbio Biopharmaceuticals Product and Solutions
Table 53. 3sbio Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Changchun High Tech Corporate Information, Head Office, and Major Competitors
Table 55. Changchun High Tech Major Business
Table 56. Changchun High Tech Biopharmaceuticals Product and Solutions
Table 57. Changchun High Tech Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. CP Guojian Corporate Information, Head Office, and Major Competitors
Table 59. CP Guojian Major Business
Table 60. CP Guojian Biopharmaceuticals Product and Solutions
Table 61. CP Guojian Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Biotech Corporate Information, Head Office, and Major Competitors
Table 63. Biotech Major Business
Table 64. Biotech Biopharmaceuticals Product and Solutions
Table 65. Biotech Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Gelgen Corporate Information, Head Office, and Major Competitors
Table 67. Gelgen Major Business
Table 68. Gelgen Biopharmaceuticals Product and Solutions
Table 69. Gelgen Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Innovent Corporate Information, Head Office, and Major Competitors
Table 71. Innovent Major Business
Table 72. Innovent Biopharmaceuticals Product and Solutions
Table 73. Innovent Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Dong Bao Corporate Information, Head Office, and Major Competitors
Table 75. Dong Bao Major Business
Table 76. Dong Bao Biopharmaceuticals Product and Solutions
Table 77. Dong Bao Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Ganlee Corporate Information, Head Office, and Major Competitors
Table 79. Ganlee Major Business
Table 80. Ganlee Biopharmaceuticals Product and Solutions
Table 81. Ganlee Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. United Laboratories Corporate Information, Head Office, and Major Competitors
Table 83. United Laboratories Major Business
Table 84. United Laboratories Biopharmaceuticals Product and Solutions
Table 85. United Laboratories Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. SANDOZ (NOVARTIS) Corporate Information, Head Office, and Major Competitors
Table 87. SANDOZ (NOVARTIS) Major Business
Table 88. SANDOZ (NOVARTIS) Biopharmaceuticals Product and Solutions
Table 89. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 91. Teva Pharmaceutical Major Business
Table 92. Teva Pharmaceutical Biopharmaceuticals Product and Solutions
Table 93. Teva Pharmaceutical Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Hospira ?Pfizer? Corporate Information, Head Office, and Major Competitors
Table 95. Hospira ?Pfizer? Major Business
Table 96. Hospira ?Pfizer? Biopharmaceuticals Product and Solutions
Table 97. Hospira ?Pfizer? Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 98. MYLAN Corporate Information, Head Office, and Major Competitors
Table 99. MYLAN Major Business
Table 100. MYLAN Biopharmaceuticals Product and Solutions
Table 101. MYLAN Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 102. Sun pharma Corporate Information, Head Office, and Major Competitors
Table 103. Sun pharma Major Business
Table 104. Sun pharma Biopharmaceuticals Product and Solutions
Table 105. Sun pharma Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 106. Global Biopharmaceuticals Revenue (USD Million) by Players (2019-2021)
Table 107. Global Biopharmaceuticals Revenue Share by Players (2019-2021)
Table 108. Breakdown of Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 109. Biopharmaceuticals Players Head Office, Products and Services Provided
Table 110. Biopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 111. Biopharmaceuticals New Entrants and Expansion Plans
Table 112. Global Biopharmaceuticals Revenue (USD Million) by Type (2016-2021)
Table 113. Global Biopharmaceuticals Revenue Share by Type (2016-2021)
Table 114. Global Biopharmaceuticals Revenue Forecast by Type (2021-2026)
Table 115. Global Biopharmaceuticals Revenue by Application (2016-2021)
Table 116. Global Biopharmaceuticals Revenue Forecast by Application (2021-2026)
Table 117. North America Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 118. North America Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 119. North America Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 120. North America Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 121. North America Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 122. North America Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 123. Europe Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 124. Europe Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 125. Europe Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 126. Europe Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 127. Europe Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 128. Europe Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 129. Asia-Pacific Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 130. Asia-Pacific Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 131. Asia-Pacific Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 132. Asia-Pacific Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 133. Asia-Pacific Biopharmaceuticals Revenue by Region (2016-2021) & (USD Million)
Table 134. Asia-Pacific Biopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 135. South America Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 136. South America Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 137. South America Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 138. South America Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 139. South America Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 140. South America Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 141. Middle East & Africa Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 142. Middle East & Africa Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 143. Middle East & Africa Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 144. Middle East & Africa Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 145. Middle East & Africa Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 146. Middle East & Africa Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biopharmaceuticals Picture
Figure 2. Global Biopharmaceuticals Revenue Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Interferon
Figure 5. Colony-Stimulating Factor
Figure 6. Erythropoietin
Figure 7. Insulin
Figure 8. Vaccines
Figure 9. Growth Hormones
Figure 10. Others
Figure 11. Biopharmaceuticals Revenue Market Share by Application in 2020
Figure 12. Tumor Picture
Figure 13. Diabetes Picture
Figure 14. Cardiovascular Picture
Figure 15. Hemophilia Picture
Figure 16. Others Picture
Figure 17. Global Biopharmaceuticals Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 18. Global Biopharmaceuticals Revenue and Forecast (2016-2026) & (USD Million)
Figure 19. Global Biopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 20. Global Biopharmaceuticals Revenue Market Share by Region in 2020
Figure 21. North America Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Europe Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Asia-Pacific Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. South America Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Middle East and Africa Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 26. Biopharmaceuticals Market Drivers
Figure 27. Biopharmaceuticals Market Restraints
Figure 28. Biopharmaceuticals Market Trends
Figure 29. Roche Recent Developments and Future Plans
Figure 30. Amgen Recent Developments and Future Plans
Figure 31. AbbVie Recent Developments and Future Plans
Figure 32. Sanofi-Aventis Recent Developments and Future Plans
Figure 33. Johnson & Johnson Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. Novo Nordisk Recent Developments and Future Plans
Figure 36. Eli Lilly Recent Developments and Future Plans
Figure 37. Novartis Recent Developments and Future Plans
Figure 38. Merck Recent Developments and Future Plans
Figure 39. Sun Recent Developments and Future Plans
Figure 40. 3sbio Recent Developments and Future Plans
Figure 41. Changchun High Tech Recent Developments and Future Plans
Figure 42. CP Guojian Recent Developments and Future Plans
Figure 43. Biotech Recent Developments and Future Plans
Figure 44. Gelgen Recent Developments and Future Plans
Figure 45. Innovent Recent Developments and Future Plans
Figure 46. Dong Bao Recent Developments and Future Plans
Figure 47. Ganlee Recent Developments and Future Plans
Figure 48. United Laboratories Recent Developments and Future Plans
Figure 49. SANDOZ (NOVARTIS) Recent Developments and Future Plans
Figure 50. Teva Pharmaceutical Recent Developments and Future Plans
Figure 51. Hospira ?Pfizer? Recent Developments and Future Plans
Figure 52. MYLAN Recent Developments and Future Plans
Figure 53. Sun pharma Recent Developments and Future Plans
Figure 54. Global Biopharmaceuticals Revenue Share by Players in 2020
Figure 55. Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 56. Global Top 3 Players Biopharmaceuticals Revenue Market Share in 2020
Figure 57. Global Top 10 Players Biopharmaceuticals Revenue Market Share in 2020
Figure 58. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 59. Global Biopharmaceuticals Revenue Share by Type in 2020
Figure 60. Global Biopharmaceuticals Market Share Forecast by Type (2021-2026)
Figure 61. Global Biopharmaceuticals Revenue Share by Application in 2020
Figure 62. Global Biopharmaceuticals Market Share Forecast by Application (2021-2026)
Figure 63. North America Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 64. North America Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 65. North America Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 66. United States Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Canada Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Mexico Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Europe Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 70. Europe Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 71. Europe Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 72. Germany Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. France Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. United Kingdom Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Russia Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Italy Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Asia-Pacific Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 78. Asia-Pacific Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 79. Asia-Pacific Biopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 80. China Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Japan Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South Korea Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. India Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Southeast Asia Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Australia Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. South America Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 87. South America Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 88. South America Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 89. Brazil Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Argentina Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. Middle East and Africa Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 92. Middle East and Africa Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 93. Middle East and Africa Biopharmaceuticals Revenue Market Share by Countr
  • Global Biopharmaceuticals Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 08-Oct-2021        Price: US 3480 Onwards        Pages: 110
    The Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest rese......
  • Global and China Bio-pharma Market Insights, Forecast to 2027
    Published: 20-Sep-2021        Price: US 3900 Onwards        Pages: 143
    Bio-pharma market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bio-pharma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Bio-pharma market size by players, ......
  • United States Biopharmaceuticals Market Report & Forecast 2021-2027
    Published: 09-Sep-2021        Price: US 3400 Onwards        Pages: 110
    United States Biopharmaceuticals Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Biopharmaceuticals Market Segment Percentages, By Type, 2020 (%) - Monoclonal Antibodies - Interferon - Colony-Stimulating Factor - Erythropoietin - Insulin - Vaccines - Growth Hormones - Others United States Biopharmaceuticals Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Biopharmaceutical......
  • Global Calcium Suppliment Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 99
    The Calcium Suppliment market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Calcium Suppliment Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Calcium Suppliment industry, providing statistical information about market dynamics, growth factors......
  • Global Advanced Wound Dressing Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 99
    The Advanced Wound Dressing market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Advanced Wound Dressing Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Advanced Wound Dressing industry, providing statistical information about market dynamics,......
  • Global Cefotaxime Sodium API Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 107
    The Cefotaxime Sodium API market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Cefotaxime Sodium API Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Cefotaxime Sodium API industry, providing statistical information about market dynamics, growt......
  • Global Empty Hard Gelatin Capsules Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 98
    Gelatin is considered to be animal proteins that are utilized to prepare capsules, which gives calculated quantities of products. Empty hard gelatin capsules are made from gelatin (Gelatin is a translucent, colorless, brittle (when dry), flavorless solid substance, derived from the collagen- an animal protein). Empty Hard Gelatin Capsules contain 12 - 16% moisture. But the moisture content can vary up on the storage conditions. The Empty Hard Gelatin Capsules market revenue was xx Million......
  • Global Phytotherapics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 117
    The Phytotherapics market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global Phytotherapics Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Phytotherapics industry, providing statistical information about market dynamics, growth factors, major chal......
  • Global P2X7 Receptor Antagonists Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries
    Published: 02-Sep-2021        Price: US 4000 Onwards        Pages: 122
    The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells. P2X7 activation results in a number of downstream events, including the release of proinflammatory mediators and cell death and proliferation. The P2X7 Receptor Antagonists market revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026. Global P2X7 Receptor Antagonists Market Develop......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs